首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:British journal of cancer

缩写:BRIT J CANCER

ISSN:0007-0920

e-ISSN:1532-1827

IF/分区:6.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引9072
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ruhina S Laskar,Neil Murphy,Pietro Ferrari et al. Ruhina S Laskar et al.
Background: Colorectal cancer (CRC) incidence is rising among adults under 55 years, but its causes remain unclear. Large-scale prospective studies are needed to identify risk factors for early-onset CRC (EOCRC). ...
Mia Aagaard Doherty,Kathrine Grell,Hanne Hove et al. Mia Aagaard Doherty et al.
Background: As larger population-based studies assessing neoplasm risk in neurofibromatosis 1 (NF1) are limited, we aimed to evaluate overall neoplasm risk, specific cancer types, and second primary cancers. ...
Shiliang Liu,Yujin Xu,Xufeng Guo et al. Shiliang Liu et al.
Purpose: Evidence on the prognostic and staging effects of lymphovascular invasion (LVI) after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (ESCC) is limited. We aimed to determine the prognostic v...
Renxuan Lin,Hiocheng Un,Youmei Kang et al. Renxuan Lin et al.
Background: Senescence plays a critical role in prostate cancer, influencing disease onset and progression. However, the alterations of senescence-associated genes during prostate cancer progression and their potential va...
Shunta Tsuchida,Tetsuro Taki,Kotaro Nomura et al. Shunta Tsuchida et al.
Background: Extranodal extension (ENE) is a recognized adverse prognostic factor in several malignancies, but its pathological basis and clinical significance in lung adenocarcinoma (LUAD) remain poorly understood. ...
Isabella R Buonopane,Erick F Saldanha,Júnior Samuel Alonso de Menezes et al. Isabella R Buonopane et al.
Hepatocellular carcinoma (HCC) relapse remains high after curative-intent treatment due to occult minimal residual disease. Circulating tumour DNA (ctDNA) has emerged as a noninvasive biomarker. Systematic search of MEDLINE, EMBASE and the ...
Xingxing Wang,Keiko Shinjo,Kohei Kumegawa et al. Xingxing Wang et al.
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is characterised by a pronounced desmoplastic reaction, predominantly composed of cancer-associated fibroblasts (CAFs), including myofibroblastic CAFs (myCAFs). ...
Rui Dong,Akshaya Srikanth,Umesh Tharehalli et al. Rui Dong et al.
Background: Hepatocellular carcinoma (HCC) often arises from chronic liver disease, but early biomarkers of malignant transformation are lacking. CD44, a transmembrane glycoprotein with multiple isoforms, has been implica...
Kinjal Gupta,Nicholas Koelsch,Victoria Neely et al. Kinjal Gupta et al.
Chemotherapy-induced tumor dormancy is a major barrier to curative cancer therapy, particularly in triple-negative breast cancer (TNBC), where dormant residual cells evade treatment and fuel late relapses. To define survival mechanisms sust...